The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
Alexander D. Douglas(University of Oxford), Andrew R. Williams(University of Oxford), Joseph J. Illingworth(University of Oxford), Gathoni Kamuyu(Kenya Medical Research Institute), Sumi Biswas(University of Oxford), Anna L. Goodman(University of Oxford), David Wyllie(University of Oxford), Cécile Crosnier(Wellcome Sanger Institute), Kazutoyo Miura(Vector Oncology (United States)), Gavin J. Wright(Wellcome Sanger Institute), Carole A. Long(Vector Oncology (United States)), Faith Osier(Kenya Medical Research Institute), Kevin Marsh(Kenya Medical Research Institute), Alison Turner(University of Oxford), Adrian V. S. Hill(University of Oxford), Simon J. Draper(University of Oxford)
Cited by 287Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis